EARLY ANEMIA IN PREMATURE NEONATAL INFANTS: PREVENTION AND TREATMENT


如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅或者付费存取

详细

The paper evaluates the impact of different types of feeding on the development and course of anemia in premature infants weighing less 1500 g at birth. It gives an account of the principles of antianemia therapy in accordance with the internal protocol. Babies on only breastfeeding supplemented with a fortifier are shown to develop severe anemia less frequently.

全文:

受限制的访问

作者简介

I. Ryumina

V.I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health and Social Development of Russia

MD Moscow

V. Zubkov

V.I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health and Social Development of Russia

Email: victor.zubkov@mail.ru
Candidate of Medical Sciences Moscow

M. Markelova

V.I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health and Social Development of Russia

Moscow

参考

  1. Arnon S., Regev R., Bauers, et al. Vitamin E levels during early iron supplementation in preterm infants // Am. J. of Perinatal. - 2009; 26 (5):387—392
  2. Bader D, Kugleman A., Maor-Rogin N. The role of high-dose oral iron supplementation during erythropoietin therapy for anemia of prematurity // J. Perinatal - 2001; 21: 215-220.
  3. Blackburn S. In Hematologic and hemostatic systems, in Maternal, Fetal, & Neonatal Physiology: A Clinical Perspective, eds St. Louis, MO: Saunders; - 2003. 213-254.
  4. Casadevall N., Nataf J., Viron B. Pure red-cell aplasia and antierythropoietin antibodies in patients treated with recombinant erythropoietin // N. Engl. J. Med. - 2002; 346: 469—475.
  5. Dame C., Juul S. The switch from fetal to adult erythropoiesis // Clin. Perinatal. - 2000; 27: 507-526.
  6. Donato H., Vain N., Rendo P. Effect of early versus late administration of human recombinant erythropoietin on transfusion requirements in premature infants: Results of a randomized, placebo-controlled, multicenter trial // Pediatrics. - 2000; 105: 1066-1072.
  7. Fomon S., Nelson S., Ziegler E. Retention of iron by infants // Annual Review of Nutrition. - 2000; 20: 273-290.
  8. Franz A., Mihatsch W., Sander S. Prospective randomized trial of early versus late enteral iron supplementation in infants with a birth weight of less than 1301 grams // Pediatrics. - 2000; 106: 700-706.
  9. Franz A., Pohlandt F. Red blood cell transfusion in very and extremely low birthweight infants under restrictive transfusion guidelines: Is exogenous erythropoietin necessary? // Arch. Dis. Child. Fetal. Neonatal. - 2001; 84: 96-100.
  10. Halamek L., Stevenson D. Neonatal jaundice and liver disease. In, eds Fanaroff AA, Martin RJ. St Louis, MO: Mosby; 2002. 1309-1350.
  11. Von Kohorn I., Ehrenkranz R. Anemia in the preterm infant: Erythropoietin versus erythrocyte transfusion - It’s not that simple // Clinics in Perinatology. - 2009; 36 (1): 111-123.
  12. John A. Widness. Pathophysiology of Anemia During the Neonatal Period, Including Anemia of Prematurity. American Academy of Pediatrics 2008.
  13. Juul S., Zerzan J., Strandjord T. Zinc protoporphyrin/heme as an indicator of iron status in NICU patients // J. Pediatr. - 2003; 142: 273-278.
  14. Kivivuori S., Virtanen M., Raivio K. Oral iron is sufficient for erythropoietin treatment of very low birth-weight infants // Eur. J. Pediatr. - 1999; 158: 147-151.
  15. Kling P., Winzerling J. Iron status and the treatment of the anemia of prematurity // Clin. Perinatol. - 2002; 29: 283-294.
  16. Luchtman-Jones L., Schwartz A., Wilson D. The blood and hematopoietic system. In eds. Fanaroff A.A., Martin R.J. St Louis, MO: Mosby; 2002. 1183-1254.
  17. Maier R., Obladen M., Müller-Hansen I. Early treatment with erythropoietin ameliorates anemia and reduces transfusion requirements in infants with birth weights below 1000 g // J. Pediatr. - 2002; 141: 8-15.
  18. Maier R., Sonntag J., Walka M. Changing practicesof red bloodcell transfusions in infants with birth weights less than 1000 g // Pediatrics. - 2000; 136: 220-224.
  19. Meyer M., Sharma E., Carsons M. Recombinant erythropoietin and blood transfusion in selected preterm infants // Arch. Dis. Child. Fetal. Neonatal. Ed. -2003; 88: 41-45.
  20. Nazir S., Peverini R., Deming D. Comparison of two iron doses in infants receiving recombinant human erythropoietin therapy // Arch. Pediatr. Adolesc. Med. - 2002; 156: 540-544.
  21. Ohls R., Ehrenkranz R., Wright L. Effects of early erythropoietin therapy on transfusion requirements of preterm infants below 1250 grams birth weight: A multicenter, randomized, controlled trial // Pediatrics. - 2001; 108: 934-942.
  22. Ohls R. Erythropoietin treatment in extremely low birth weight infants: Blood in versus blood out // J. Pediatr. - 2002; 141: 3-6.
  23. Ohls R. The use of erythropoietin in neonates // Clin. Perinatol. - 2000; 27: 381-696.
  24. Pathak A., Roth R., Piscitelli J. Effects of vitamin E supplementation during erythropoietin treatment of the anaemia of prematurity // Arch. Dis. Child. Fetal. Neonatal. Ed. - 2003; 88: 324-328.
  25. Pollak A., Hayde M., Hayn M. Effect of intravenous iron supplementation on erythropoiesis in erythropoietin-treated premature infants // Pediatrics. - 2001; 107: 78-85.
  26. Reiter P., Rosenberg A., Valuck R. Factors associated with successful epoetin alfa therapy in premature infants // Ann. Pharmacother. - 2000; 34: 433-439.
  27. Salsbury D. Anemia of prematurity // Neonatal. Network. - 2001; 20: 13-20.
  28. Strauss R. Managing the anemia of prematurity: Red blood cell transfusions versus recombinant erythropoietin // Transfus. Med. Rev. - 2001; 15: 213-223.
  29. Сахарова Е. С., Кешишян Е. С. Анемия у недоношенных детей // Consilium Medicum. - 2002. Приложение: Педиатрия: 31-33.

补充文件

附件文件
动作
1. JATS XML
下载
##common.cookie##